LabCorp launches new COVID-19 clinical trial site to connect patients with U.S. research trials

Streamlining recruitment into studies to speed research

Labcorp accelerates adoption of decentralized clinical trials, expands technology ecosystem through alliance with Medable

BURLINGTON, N.C. --(BUSINESS WIRE)--May 28, 2020-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate the adoption of decentralized clinical trials, often referred to as hybrid and virtual clinical trials.

Roche highly accurate antibody test for COVID-19 goes live at more than 20 initial lab sites in the US

LabCorp and other commercial labs will have the ability to perform more than 2 million tests per week by June